With over 70 years in the pharma industry and 280 different pharmaceutical products, Rekah is working to increase its international presence by focusing on out-licensing, in-licensing, establishing new partnerships and executing mergers and acquisitions.
We are focusing on adjusting our corticosteroid product line and additional niche products to regulatory requirements abroad.